TEVA Teva Pharmaceutical Industries Ltd

Price (delayed)

$33.08

Market cap

$38.52B

P/E Ratio

24.15

Dividend/share

N/A

EPS

$1.37

Enterprise value

$51.69B

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 82
Relative Valuation: Rel. Valuation: 75
Relative Profitability: Rel. Profitability: 87
Highlights
Teva Pharmaceutical Industries's equity has increased by 31% YoY and by 4% QoQ
TEVA's quick ratio is up by 15% YoY

Key stats

What are the main financial stats of TEVA

TEVA stock price

How has the Teva Pharmaceutical Industries stock price performed over time
Intraday
2.73%
1 week
0.52%
1 month
-2.91%
1 year
94.93%
YTD
5.99%
QTD
9.83%

Financial performance

How have Teva Pharmaceutical Industries's revenue and profit performed over time
Revenue
$17.35B
Gross profit
$9.03B
Operating income
$2.29B
Net income
$1.56B
Gross margin
52.1%
Net margin
9%
The gross profit rose by 11% year-on-year
TEVA's net income is up by 11% since the previous quarter
The net margin has increased by 10% since the previous quarter
TEVA's gross margin is up by 6% YoY

Price vs fundamentals

How does TEVA's price correlate with its fundamentals

Growth

What is Teva Pharmaceutical Industries's growth rate over time

Valuation

What is Teva Pharmaceutical Industries stock price valuation
P/E
24.15
P/B
4.62
P/S
2.2
EV/EBIT
22.45
EV/EBITDA
15.66
EV/Sales
2.98
Teva Pharmaceutical Industries's EPS has increased by 11% QoQ
TEVA's price to book (P/B) is 105% higher than its 5-year quarterly average of 2.2 and 22% higher than its last 4 quarters average of 3.7
Teva Pharmaceutical Industries's equity has increased by 31% YoY and by 4% QoQ
The P/S is 115% above the 5-year quarterly average of 1.0 and 26% above the last 4 quarters average of 1.7
TEVA's revenue is up by 4.4% year-on-year

Efficiency

How efficient is Teva Pharmaceutical Industries business performance
TEVA's ROE has soared by 197% YoY and by 3.5% from the previous quarter
Teva Pharmaceutical Industries's return on assets has increased by 11% QoQ
The company's return on invested capital rose by 9% QoQ
Teva Pharmaceutical Industries's return on sales has increased by 6% QoQ

Dividends

What is TEVA's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Teva Pharmaceutical Industries financials performed over time
The total assets is 26% greater than the total liabilities
TEVA's quick ratio is up by 15% YoY
The total assets is up by 4.2% year-on-year
The debt is 105% greater than the equity
Teva Pharmaceutical Industries's equity has increased by 31% YoY and by 4% QoQ
TEVA's debt to equity is down by 24% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.